Padlock Therapeutics' Acquisition

Padlock Therapeutics was acquired by Bristol-Myers Squibb on March 23, 2016.

Padlock Therapeutics is a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. The company leverages the science …

Articles about Padlock Therapeutics' Acquisition: